Compare ICICI Prudential Nifty Pharma Index Fund vs UTI Healthcare Fund
ICICI Prudential Nifty Pharma Index Fund
EquitySectoral-Pharma
UTI Healthcare Fund
EquitySectoral-Pharma
Risk
Very High
Very High
Rating
2.0
4.0
Min SIP Amount
₹1000
₹500
Expense Ratio
1.18
2.22
NAV
₹19.96
₹364.62
Fund Started
25 Nov 2022
01 Aug 2005
Fund Size
₹163.10 Cr
₹1429.84 Cr
Exit Load
-
Exit load of 1% if redeemed within 30 days.
1 Year
16.02%
9.16%
3 Year
18.66%
20.14%
5 Year
-
13.16%
Equity
99.94%
94.12%
Cash
0.06%
5.85%
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 19.50% |
Divi's Laboratories Ltd. | 11.97% |
Laurus Labs Ltd. | 7.82% |
Cipla Ltd. | 7.68% |
Dr. Reddy's Laboratories Ltd. | 7.62% |
Torrent Pharmaceuticals Ltd. | 7.16% |
Lupin Ltd. | 5.00% |
Aurobindo Pharma Ltd. | 4.68% |
Glenmark Pharmaceuticals Ltd. | 3.56% |
Alkem Laboratories Ltd. | 3.16% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 7.62% |
Divi's Laboratories Ltd. | 6.15% |
Dr. Reddy's Laboratories Ltd. | 5.24% |
Ajanta Pharma Ltd. | 4.81% |
Gland Pharma Ltd. | 4.06% |
Alkem Laboratories Ltd. | 3.70% |
Apollo Hospitals Enterprise Ltd. | 3.03% |
Caplin Point Laboratories Ltd. | 3.02% |
Global Health Ltd. | 2.96% |
Lupin Ltd. | 2.89% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to invest in companies whose securities are included in Nifty Pharma Index and subject to tracking errors, to endeavor to achieve the returns of the above index. This would be done by investing in all the stocks comprising the Nifty Pharma Index in the same weightage that they represent in Nifty Pharma Index
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
Launch Date
25 Nov 2022
01 Aug 2005
